Chemiluminescence and spectrofluorimetric methods for determination of fluoroquinolones: A review

Analytical Letters

Volumn 44, Issue 9, 2011, Pages 1602-1639

  Kaur, Kuldeep ^a   Singh, Baldev ^a   Malik, Ashok Kumar ^a  

^a PUNJABI UNIVERSITY   (India)

Author keywords

Determination; Fluoroquinolones; Luminescence; Spectrofluorimetric

Indexed keywords

EID: 79959502304     PISSN: 00032719     EISSN: 1532236X     Source Type: Journal    
DOI: 10.1080/00032719.2010.520392     Document Type: Review

References (148)

1. Abdel-Hay, M. H., E. M. Hassan, A. A. Gazy, and T. S. Belal. 2008. Kinetic Spectrophotometric analysis and spectrofluorimetric analysis of ciprofloxacin hydrochloride and norfloxacin in pharmaceutical preparations using 4-chloro-7-nitrobenzo-2-oxa-1,3-diazole (NBD-CI). J. Chin. Chem. Soc. 55: 817-827.
2. Ahmed, A. K. S., M. Abdel Kawy, and M. Nebsen. 1997. Spectrophotometric and spectrofluorimetric determination of pefloxacin. Anal. Lett. 30: 809-820.
3. Alam, S. M., and S. H. Lee. 2008. Flow injection chemiluminescence determination of sparfloxacin using potassium permanganate-sodium sulfite system. Appl. Chem. 12: 97-100.
4. 3 ]-Ce(IV) system. Talanta 53: 885-893.
5. Ayla, T. 1990. Adsorptive stripping voltammetric determination of ofloxacin. Anal. Chim. Acta 231: 129-131.
6. Ballesteros, O., J. L. Vilchez, and A. Navalon. 2000. Determination of the antibacterial ofloxacin in human urine and serum samples by solid-phase spectrofluorimetry. J. Pharm. Biomed. Anal. 30: 1103-1110.
7. Ballesteros, O., J. L. Vílchez, J. Taoufiki, and A. Navalon. 2004. Determination of the antibacterial drug enrofloxacin by solid-phase spectrofluorimetry. Microchim. Acta 148: 227-233.
8. Chen, G., and M. J. Schneider. 2003. A rapid spectrofluorometric screening method for enrofloxacin in chicken muscle. J. Agric. Food Chem. 51: 3249-3253.
9. 2+-Ce(IV) system and its application. Luminescence 23: 309-315.
10. Chen, S., H. Ma, H. Zhao, R. Feng, and L. Jin. 2004. Terbium-sensitized fluorescence method for the determination of pazufloxacin mesilate and its application. Anal. Sci. 20: 1075-1078.
11. Chen, S. L., F. Ding, Y. Liu, and H. C. Zhao. 2006. Electrochemiluminescence of terbium (III)-two fluoroquinolones-sodium sulfite system in aqueous solution. Spectrochim. Acta A 64: 130-135.
12. Chen, S. L., Y. Liu, H. C. Zhao, L. P. Jin, Z. L. Zhang, and Y. Z. Zheng. 2006. Determination of norfloxacin using a terbium-sensitized electrogenerated chemiluminescence method. Luminescence 21: 20-25.
13. Christian, H., and B. Gottfried. 2001. Development of capillary electrophoresis methods for the analysis of fluoroquinolones and application to the study of the influence of humic substances on their photodegradation in aqueous phase. J. Chromatogr. B 754: 168-178.
14. Chun, Z. H., F. R. Qin, W. X. Bin, and Y. Lin. 2002. Terbium sensitized fluorescence determination of tosufloxacin. Chinese J. Lab. Anal. 5: 2-4.
15. D'Agostino, P. A., J. A. Hancock, and L. R. Provost. 2005. Electrospray mass spectrometric characterization of fluoroquinolone antibiotics: Norfloxacin, enoxacin, ciprofloxacin and ofloxacin. Rapid Comm. Mass-Spectrom. 9: 1038-1043.
16. Djurdjevic, P. T., M. J. Stankov, and D. Stankov. 1995. Fluorescence reaction and complexation equilibria between norfloxacin and aluminium (III) ion in chloride medium. Anal. Chim. Acta 300: 253-259.
17. Drakopoulos, A. I., and P. C. Ioannou. 1997. Spectrofluorimetric study of the acid-base equilibria and complexation behavior of the fluoroquinolone antibiotics ofloxacin, norfloxacin, ciprofloxacin and pefloxacin in aqueous solution. Anal. Chim. Acta 354: 197-204.
18. Du, J., Y. Li, and J. Lu. 2005. Chemiluminescence determination of fluoroquinolone antibiotics using a soluble manganese (IV)-sulphite system. Luminescence 20: 30-35.
19. Du, L. M., X. M. Cao, and H. Y. Wu. 2003. Direct determination of enoxacin in human plasma by micellar enhancing effect-synchronous fluorimetry. Chin. J. Anal. Chem. 31: 1330.
20. Du, L. M., J. P. Wang, and C. X. Wang. 2004. The fluorescence characteristics of micelle inclusion of pefloxacin and its application. Guan Guang Pu Xue Yu G Pu Fen Xi 24: 855-857.
21. Du, L. M., Y. Q. Yang, and Q. M. Wang. 2004. Spectrofluorometric determination of certain quinolone through charge transfer complex formation. Anal. Chim. Acta 516: 237-243.
22. Du, L. M., H. Y. Yao, and M. Fu. 2005. Spectrofluorimetric study of the charge-transfer complexation of certain fluoroquinolones with 7,7,8,8-tetracyanoquinodimethane. Spectrochim. Acta A 61: 281-286.
23. Durmus, Z., E. Canel, and E. Kiliq. 2005. Spectrofluorimetric assay of ciprofloxacin hydrochloride in tablets. Anal. Quant. Cytol. Histol. 27: 162-166.
24. El-Brashy, A. M., M. E. Metwally, and F. A. El-Sepai. 2004. Spectrophotometric determination of some fluoroquinolone antibacterials through charge transfer and ion pair complexation reactions. Bull. Kor. Chem. Soc. 25: 365-372.
25. El-Kommos, M. E., G. A. Saleh, S. M. El-Gizawi, and M. A. Abou-Elwafa. 2003. Spectrofluorometric determination of certain quinolone antibacterials using metal chelation. Talanta 60: 1033-1050.
26. El-Walily, A. M., S. F. Belal, and R. S. Bakry. 1996. Spectrophotometric and spectrofluorimetric estimation of ciprofloxacin and norfloxacin by ternary complex formation with eosin and palladium (II). J. Pharma. Biomed. Anal. 14: 561-569.
27. El-Yazbi, F. A. 1992. Spectrophotometric and spectrofluorimetric determination of ofloxacin. Spectrosc. Lett. 25: 279-291.
28. Ernst, M. E., E. J. Ernst, and M. E. Klepser. 1997. Levofloxacin and trovafloxacin: The next generation of fluoroquinolones. Am. J. Health. Sys. Pharm. 54: 2569-2584.
29. Fangtian, Y., Z. Tieli, J. Linpei, Z. Huichun, and W. Shubin. 1999. Observations on photochemical fluorescence enhancement of the terbium(III)-sparfloxacin system. Spectrochim. Acta A 55A: 1119-1125.
30. Farina, A. 1989. Fluorimetric assay of rufloxacin in serum and in pharmaceutical formulations. J. Pharm. Biomed. Anal. 7: 1579-1583.
31. Fengshan, Y., Z. Dazhai, W. Kangbing, and C. Fang. 2008. Sensitive determination of prulifloxacin by its fluorescence enhancement on terbium(III)-sodium dodecylbenzene sulfonate system. Anal. Lett. 41: 3124-3137.
32. Fengshan, Y., L. Weizhou, C. Fang, and C. Ping. 2008. Highly sensitive spectrofluorimetric determination of trace amounts of prulifloxacin using the aluminium(III)-prulifloxacin system. Luminescence 23: 429-433.
33. Fengshan, Y., G. Yongwei, C. Man, C. Fang, and D. Yanbin. 2008. Fluorescence probe enhanced spectrofluorimetric method for the determination of prulifloxacin in pharmaceutical formulations and biological fluids. Anal. Lett. 41: 2933-2943.
34. Geffken, D., and H. Salem. 2006. Spectrofluorimetric study of the charge-transfer complexation of certain fluoroquinolones with 2,3,5,6-tetrafluoro-p-bezoquinone. Am. J. Appl. Sci. 3: 1952-1960.
35. Ghoneim, R. A., A. Radi, and A. M. Beltagi. 2001. Determination of norfloxacin by square-wave adsorptive voltammetry on a glassy carbon electrode. J. Pharma. Biomed. Anal. 25: 205-210.
36. Guo, C., P. Dong, Z. Chu, L. Wang, and W. Jiang. 2008. Rapid determination of gatifloxacin in biological samples and pharmaceutical products using europium-sensitized fluorescence spectrophotometry. Luminescence 23: 7-13.
37. Guo, C., L. Wang, Z. Hou, W. Jiang, and L. Sang. 2008. Micelle-enhanced and terbium-sensitized spectrofluorimetric determination of gatifloxacin and its interaction mechanism. Spectrochim. Acta A 72: 766-771.
38. Gurumurthy, P., G. Ramachandran, A. K. Hemanth Kumar, P. Venkatesan, V. Chandrasekharan, and P. R. Narayanan. 1998. Simple spectrofluorimetric and microbiological assay methods for the estimation of ofloxacin in biological fluids. Ind. J. Pharmacol. 30: 263-266.
39. Han, Y. X., X. Wu, J. H. Yang, and S. N. Sun. 2005. The fluorescence characteristic of the yttrium-norfloxacin system and its analytical application. J. Pharm. Biomed. Anal. 38: 528-531.
40. He, Y., J. Lu, H. Zhang, and J. Du. 2005. Molecular imprinting-chemiluminescence determination of norfloxacin using a norfloxacin-imprinted polymer as the recognition material. Microchim. Acta 149: 239-244.
41. Hernandez, J. A., R. Compano, R. Ferrer, and M. D. Prat. 2000. Application of principal component regression to luminescence data for the screening of ciprofloxacin and enrofloxacin in animal tissues. Analyst 125: 1155-1158.
42. Hernandez, J. A., R. Compano, and M. D. Prat. 1998. Determination of ciprofloxacin and enrofloxacin in edible animal tissues by terbium-sensitized luminescence. Analyst 123: 2729-2732.
43. Hernandez, M., F. Borrull, and M. Calull. 2002. Using nonaqueous capillary electrophoresis to analyze several quinolones in pig kidney samples. Electrophoresis 23: 506-511.
44. Hooper, D. C., and J. S. Wolfson. 1993. Mechanism of quinolne action and bacterial killing. In Quinolone Antimicrobial Agents, 2nd ed. Washington, D.C.: American Society for Microbiology, 53-75.
45. Huang, Z., R. Cai, K. Zhang, H. Huang, and Y. Zeng. 1997. Micelle enhanced spectrofluorimetric determination of norfloxacin using terbium as fluorescent probe. Anal. Lett. 30: 1531-1539.
46. Jaber, A. M. Y., and A. Lounici. 1994. Polarographic behaviour and determination of norfloxacin in tablets. Anal. Chim. Acta 291: 53-64.
47. 3+ system. Appl. Chem. 11: 445-448.
48. Jurado, J. M., and J. A. Ocana. 2007. Fluorometric determination of mixtures of quinolones by means of partial least squares and neural networks. Anal. Sci. 23: 337-341.
49. th International Symposium. pp. 205.
50. 3 -Ce(IV) system. Appl. Chem. 11: 433-436.
51. Karim, M. M., and S. H. Lee. 2008. Determination of enoxacin using Tb composite nanoparticles sensitized luminescence method. J. Fluoresc. 18: 827-833.
52. Karim, M. M., S. H. Lee, H. S. Lee, Z. U. Bae, and K. H. Choi. 2006. A batch chemiluminescence determination of enoxacin using a tris-(1,10-phenanthroline) ruthenium(II)- cerium(IV) system. J. Fluoresc. 16: 535-540.
53. Kaur, K., A. Kumar, A. K. Malik, B. Singh, and A. L. J. Rao. 2008. Spectrophotometric methods for determination of fluoroquinolones: A Review. Crit. Rev. Anal. Chem. 38: 2-18.
54. Kilic, E., F. Koseoglu, and M. A. Akayt. 1994. The non-aqueous titrimetric assay of selected antibiotics using tetra-N-butylammonium hydroxide as titrant. J. Pharma. Biomed. Anal. 12: 347-352.
55. Li, J. J., Z. L. Zhang, L. B. Qu, and R. Yang. 2009. Determination of pazufloxacin mesylas by terbium sensitized chemiluminescence method. Guang Pu Xue Yu Guang Pu Fen Xi 29: 73-77.
56. Li, L., H. Sun, and X. Chen. 2008. Flow-Injection chemiluminescence analysis of lomefloxacin in drugs and biological fluids. Curr. Anal. Chem. 4: 152-156.
57. Lian, N., H. C. Zhao, C. Y. Sun, S. L. Chen, Y. Lu, and L. P. Jin. 2003. A study on terbium sensitized chemiluminescence of ciprofloxacin and its application. Microchem. J. 74: 223-230.
58. Liang, Y. D., J. F. Song, and X. F. Yang. 2004. Flow-injection chemiluminescence determination of fluoroquinolones by enhancement of weak chemiluminescence from peroxynitrous acid. Anal. Chim. Acta 510: 21-28.
59. Liao, S. L., and Z. H. Xie. 2005. Determination of norfloxacin by flow-injection chemiluminescence. Guang Pu Xue Yu Guang Pu Fen Xi 25: 1938-1942.
60. Liming, D., X. Qingqin, and Y. Jianmei. 2003. Fluorescence spectroscopy determination of fluoroquinolones by charge-transfer reaction. J. Pharm. Biomed. Anal. 33: 693-698.
61. Liu, Y., S. Chen, H. Zhao, and L. Jin. 2005. Terbium sensitized determination of tosufloxacin using electrochemiluminescence method. Anal. Sci. 21: 373-375.
62. Liu, Z. H., Z. Y. Huang, and R. X. Cai. 2000. Study of the fluorescence characteristics of norfloxacin in reversed micelles and application in analysis. Analyst 125: 1477-1481.
63. Ma, H., R. Tian, X. Sun, and X. Liu. 2008. Study of the direct determination of loefloxacin in urine with aluminium(III)-lomefloxacin-SDS system by synchronous fluorimetry. Luminescence 23: 59-114.
64. Ma, H., X. Zheng, and Z. Zhang. 2005. Flow-injection electrogenerated chemiluminescence determination of fluoroquinolones based on its sensitizing effect. Luminescence 20: 303-306.
65. Man, C., Y. Fengshan, C. Fang, and C. Lanhua. 2008. A direct chemiluminescence method for the determination of prulifloxacin using tris-(4,7-diphenyl-1,10-phenanthrolinedisulfonic acid) ruthenium(II)-cerium(IV) system. Anal. Lett. 41: 2001-2012.
66. Mansilla, A. E., A. M. Pena, F. Canada, and D. G. Gomez. 2005. Determination of fluoroquinolones and nonsteroidal anti-inflammatory drugs in urine by extractive spectrophotometry and photoinduced spectrofluorimetry using multivariate calibration. Anal. Biochem. 347: 275-286.
67. Mansilla, A. E., A. M. Pena, D. G. Gomez, and F. Salinas. 2005. HPLC determination of enoxacin, ciprofloxacin, norfloxacin and ofloxacin with photoinduced fluorimetric (PIF) detection and multiemission scanning: Application to urine and serum. J. Chromatogr. B 822: 185-193.
68. Mansilla, A. E., A. M. Pena, F. Salinas, and D. G. Gomez. 2004. Partial least squares multicomponent fluo rimetric determination of fluoroquinolones in human urine samples. Talanta 62: 853-860.
69. Martinez, E. J., J. F. Garcia-Reyes, P. W. Barrales, and A. M. Diaz. 2005. Terbium-sensitized luminescence optosensor for the determination of norfloxacin in biological fluids. Anal. Chim. Acta 532: 159-164.
70. Mostafa, S., M. El-Sadek, and E. A. Alla. 2002. Spectrophotometric determination of ciprofloxacin, enrofloxacin and pefloxacin through charge transfer complex formation. J. Pharm. Biomed. Anal. 27: 133-142.
71. Murillo, J. A., M. A. Alanon, P. A. Munoz, M. I. Duran, and G. A. Jimenez. 2007. Resolution of ofloxacin-ciprofloxacin and ofloxacin-norfloxacin binary mixtures by flow-injection chemiluminescence in combination with partial least squares multivariate calibration. J. Fluoresc. 17: 481-491.
72. Murugesan, N., S. C. Mathur, Y. Kumar, Y. K. S. Rathore, and P. D. Sethi. 1992. Spectrofluorimetric determination of ofloxacin. East. Pharm. 35: 117-118.
73. Navalon, A., O. Ballesteros, R. Blanc, and J. L. Vilchez. 2000. Determination of ciprofloxacin in human urine and serum samples by solid-phase spectrofluorimetry. Talanta 52: 845-852.
74. Neckel, U., C. Joukhadar, M. Frossard, W. Jager, M. Muller, and B. X. Mayer. 2002. Simultaneous determination of levofloxacin and ciprofloxacin in microdialysates and plasma by high-pressure liquid chromatography. Anal. Chim. Acta 463: 199-206.
75. Nie, L. H., H. C. Zhao, X. Wang, L. Yi, Y. Lu, J. P. Jin, and H. M. Ma. 2002. Determination of lomefloxacin by terbium sensitized chemiluminescence method. Anal. Bioanal. Chem. 374: 1187-1190.
76. Ocana, J. A., F. J. Barragan, and M. Callejon. 2000a. Spectrofluorimetric determination of levofloxacin in tablets, human urine and serum. Talanta 52: 1149-1156.
77. Ocana, J. A., F. J. Barragan, and M. Callejon. 2000b. Spectrofluorimetric determination of moxifloxacin in tablets, human urine and serum. Analyst 125: 2322-2325.
78. Ocana, J. A., F. J. Barragan, and M. Callejon. 2000c. Terbium-sensitized luminescence determination of levofloxacin in tablets and human urine and serum. Analyst 125: 1851-1854.
79. Ocana, J. A., F. J. Barragan, and M. Callejon. 2001. Application of terbium-sensitized luminescence for the determination of grepafloxacin in human urine and serum. J. Pharma. Sci. 90: 1553-1557.
80. Ocana, J. A., F. J. Barragan, and M. Callejon. 2005. Spectrofluorimetric and micelle-enhanced spectrofluorimetric determination of gatifloxacin in human urine and serum. J. Pharma. Biomed. Anal. 37: 327-332.
81. Ocana, J. A., F. J. Barragan, M. Callejon, and F. de la-Rosa. 2004. Application of lanthanide sensitised chemiluminescence to the determination of levofloxacin, moxifloxacin and trovafloxacin in tablets. Microchim. Acta 144: 207-213.
82. Ocana, J. A., M. Callejon, and F. J. Barragan. 2001. Determination of trovafloxacin in human serum by time resolved terbium-sensitised luminescence. Eur. J. Pharm. Sci. 13: 297-301.
83. Ocana, J. A., M. Callejon, F. J. Barragan, and F. F. de-la-Rosa. 2003. Lanthanide sensitized chemiluminescence determination of grepafloxacin in tablets and human urine. Anal. Chim. Acta 482: 105-113.
84. Ortiz, M. C., L. A. Sarabia, M. S. Sánchez, and D. Gimenez. 2009. Identification and quantification of ciprofloxacin in urine through excitation-emission fluorescence and three-way PARAFAC calibration. Anal. Chim. Acta 642: 193-205.
85. Panadero, S., A. Gomez-Hens, and D. Perez-Bendito. 1995. Stopped flow kinetic determination of nalidixic acid and norfloxacin based on lanthanide-sensitized fluorescence. Anal. Chim. Acta 303: 39-45.
86. Pulgarin, J. A. M., A. A. Mollina, and L. M. Fernandez. 2008. Determination of ciprofloxacin, the major metabolite of enrofloxacin, in milk by isopotential fluorimetry. J. Agric. Food Chem. 56: 8838-8843.
87. Rao, Y., Y. Tong, X. Zhang, G. Luo, and W. R. G. Baeyens. 2000. Flow-Injection chemiluminescence determination of fluoroquinolones. Anal. Lett. 33: 1117-1129.
88. 3 -Ce(IV) system and central composite design for the optimization of chemical variables. Luminescence 23: 357-364.
89. Rizk, M., F. Belal, F. Ibrahim, S. Ahmed, and N. El-Enany. 2000. Spectrofluorimetric analysis of certain 4-quinolone in pharmaceuticals and biological fluids. Pharm. Acta Helvetiae 74: 371-377.
90. Rodriguez-Diaz, R. C., M. P. Aguilar-Caballor, and A. G. Henz. 2003. Simultaneous determination of ciprofloxacin and tetracycline in biological fluids based on dual-lanthanide sensitised luminescence using dry reagent chemical technology. Anal. Chim. Acta 494: 55-62.
91. Rodriguez-Diaz, R. C., Aguilar-Caballor, and A. G. Henz. 2004. Sensitive determination of fluoroquinolone antibiotics in milk samples using time resolved methodology. Anal. Letters 37: 1163-1175.
92. Ross, D. L., and C. M. Riley. 1990. Aqueous solubilities of variously substituted quinolone antimicrobials. Intl. J. Pharm. 63: 237-250.
93. Ruiz, T. P., C. M. Lozano, V. Tomas, and J. Carpena. 1997. Determination of norfloxacin in real samples by different spectrofluorimetric techniques. Analyst 122: 705.
94. Salem, H. 2005. Spectrofluorimetric, atomic absorption spectrometric and spectrophotometric determination of some fluoroquinolones. Am. J. Appl. Sci. 2: 719-729.
95. Salem, H., L. Fada, and W. Khater. 2007. Spectrofluorimetric determination of certain fluoroquinolones through charge transfer complex formation. Am. J. Pharm. Toxi. 2: 18-25.
96. Shao, X., Y. Li, Y. Liu, and Z. Song. 2009. Flow injection chemiluminescence determination of levofloxacin in medicine and biological fluids based on its enhancing effect on luminol-H2O2 reaction. Spectroscopy 23: 209-216.
97. Shao, X., X. Xie, Y. Li, Y. Liu, and Z. Song. 2006. Rapid determination of levofloxacin at nanogram level in pharmaceuticals and biological fluids using flow injection chemiluminescence. Curr. Anal. Chem. 2: 253-259.
98. Shao, X. D., H. Y. Liu, X. F. Gao, W. Q. Chen, and Z. H. Song. 2007. Determination of norfloxacin in pharmaceuticals, human serum, and urine using a luminol-dissolved oxygen chemiluminescence system. Chem. Papers 61: 353-358.
99. Shi, J., P. Feng, L. Zhao, and Q. G. Song. 2006. Flow injection chemiluminescence determination of sparfloxacin. J. Lab. Anal. 25: 89-91.
100. Shtykov, S. N., T. D. Smirnova, Y. G. Bylinkin, N. V. Kalashnikova, and D. A. Zhemerichkin. 2007. Determination of ciprofloxacin and enrofloxacin by the sensitized fluorescence of europium in the presence of the second ligand and micelles of anionic surfactants. J. Anal. Chem. 62: 136-140.
101. Sun, C., N. Lian, H. Zhao, L. Yi, and L. Jin. 2004. Flow injection determination of lomefloxacin based on photochemically sensitized chemiluminescence. Microchim. Acta. 148: 65-70.
102. Sun, C. Y., H. C. Zhao, L. Yi, and Y. Lu. 2002. Flow injection analysis of sparfloxacin by photochemical sensitized chemiluminescence method. Chin. J. Anal. Chem. 30: 920-924.
103. Sun, H., P. Chen, F. Wang, and H. Wen. 2009. Investigation on enhanced chemiluminescence reaction systems with bis(hydrogenperiodato) argentate(III) complex anion for fluoroquinolones synthetic antibiotics. Talanta 79: 134-140.
104. Sun, H., L. Li, and X. Chen. 2006. Flow-Injection chemiluminescence determination of ofloxacin and levofloxacin in pharmaceutical preparations and biological fluids. Anal. Sci. 22: 1145-1149.
105. Sun, H., L. Li, and X. Chen. 2008. Determination of gatifloxacin in injection solutions and urine by europium-sensitized chemiluminescence. Asian J. Pharm. Sci. 3: 168-174.
106. Sun, H., L. Li, X. Chen, H. Shi, and Y. Lu. 2006. Determination of norfloxacin by flow injection analysis with chemiluminescence detection. Can. J. Anal. Sci. Spectrosc. 51: 100-107.
107. Sun, H., Y. Wu, and L. Li. 2009. Dysprosium-sensitized chemiluminescence system for the determination of enoxacin in pharmaceutical preparations and biological fluids with flow-injection sampling. Drug Test. Anal. 1: 128-134.
108. Sun, H. W., L. Q. Li, and X. Y. Chen. 2006. Flow-injection enhanced chemiluminescence method for determination of ciprofloxacin in pharmaceutical preparations and biological fluids. Anal. Bioanal. Chem. 384: 1314-1319.
109. Sweetman, S. C., P. S. Blake, J. M. McGlashan, and A. V. Parsons, Eds. 2002. Martindale: The extra pharmacopoeia, 33rd ed. London: Royal Pharmaceutical Society.
110. Tian, W., and Z. Zhang. 2008. Flow injection chemiluminescence sensor for determination of ofloxacin in serum. J. Shaanxi Norm. U. 36: 48-51.
111. Tieli, Z., Z. Huichun, and J. Linpei. 1999. Photochemical fluorescence enhancement of the terbium-lomefloxacin complex and its application. Talanta 49: 77-82.
112. Tong, C., and G. Xiang. 2006. Sensitive determination of norfloxacin by the fluorescence probe of terbium (III)- sodium dodecyl benzene sulfonate and its luminescence mechanism. J. Fluoresc. 16: 831-837.
113. Tong, C., and G. Xiang. 2007. Sensitive determination of enoxacin by its enhancement effect on the fluorescence of terbium(III)-sodium dodecylbenzene sulfonate and its luminescence mechanism. J. Lumin. 126: 575-580.
114. Tong, C. L., G. H. Xiang, and W. P. Liu. 2005. Determination of ciprofloxacin in urine using terbium ion as fluorescent probe. Guang Pu Xue Yu Guang Pu Fen Xi 25: 2061-2064.
115. Ulu, S. T. 2009a. Rapid and sensitive spectrofluorimetric determination of enrofloxacin, levofloxacin and ofloxacin with 2,3,5,6-tetrachloro-p-benzoquinone. Spectrochim. Acta A 72: 1038-1042.
116. Ulu, S. T. 2009b. Highly sensitive spectrofluorimetric determination of lomefloxacin in spiked human plasma, urine and pharmaceutical preparations. Eur. J. Med. Chem. 44: 3402-3405.
117. Veiopoulou, C. J., P. C. Ioannou, and E. S. Lianidou. 1997. Application of terbium sensitized fluorescence for the determination of fluoroquinolone antibiotics pefloxacin, ciprofloxacin and norfloxacin in serum. J. Pharm. Biomed. Anal. 15: 1839-1844.
118. Venugopal, K., S. Movva, and R. N. Saha. 2006. New, rapid, and sensitive spectrofluorimetric method for the estimation of gatifloxacin in bulk and formulations. Indian J. Pharm. Sci. 68: 726-730.
119. Vilchez, J. L., J. Taoufiki, O. Ballesteros, and A. Navalon. 2005. Micelle enhanced spectrofluorimetric method for the determination of antibacterial trovafloxacin in human urine and serum. Microchim. Acta 150: 247-252.
120. Vilchez, J. L., J. Taoufiki, and A. Navalon. 2002. Determination of the antibacterial drug trovafloxacin by solid-phase spectrofluorimetry. Anal. Lett. 35: 257-268.
121. Wang, L., C. Guo, Z. Chu, and W. Jiang. 2009. Luminescence enhancement effect for the determination of balofloxacin with balofloxacin-europium (III)-sodium dodecylbenzene sulfonate system. J. Lumin. 129: 90-94.
122. Wang, L., L. H. Sang, Y. L. Wu, X. M. Cheng, Z. D. Su, and A. H. Yu. 2001. Guang Pu Xue Yu Guang Pu Fen Xi (Spectroscopy and Spectral Analysis) 21: 691-693.
123. Wang, L., B. Yang, Y. Li, H. Chen, M. Li, and F. Luo. 2007. A flow injection chemiluminescence method for the determination of fluoroquinolone derivative using the reaction of luminol and hydrogen peroxide catalyzed by gold nanoparticles. Talanta 72: 1066-1072.
124. Wang, R., J. Yong, M. Sheng, J. Li, and W. Zheng. 2009. Chemiluminescent determination of pefloxacin mesylate. Chin. J. Antibiot. 34: 251-253.
125. Wang, X., H. Zhang, L. Nie, L. Jin, and Z. Zhang. 2001. Europium sensitized chemiluminescense determination of rufloxacin. Anal. Chim. Acta 445: 169-175.
126. Wang, X., and H. C. Zhao. 2001. Terbium sensitized chemiluminescence of enoxacin. Yao Xue Xue Bao (Acta Pharmaceutica Sinica) 6: 613-615.
127. Wang, X. L., S. L. Chen, H. C. Zhao, L. P. Jin, and L. Xia. 2005. Europium sensitized chemiluminescence determination of pazufloxacin mesylate in urine and serum. Anal. Lett. 38: 971-979.
128. Wang, Y., L. Feng, and C. Jiang. 2005. Fluorimetric study of the interaction between human serum albumin and quinolones-terbium complex and its application. Spectrochim. Acta A 61: 2909-2914.
129. Wei, L., X. Cheng, J. M. Lin, H. Cai, and F. Huang. 2009. Chemiluminescence mechanisms of cerium-norfloxacin and its application in urine analysis. Chem. Papers 63: 358-365.
130. Wenbing, D. 2008. Reverse micelles chemiluminescence determination of pefloxacin mesylate. J. Sichuan U. 45(1).
131. Xie, X., X. Shao, Q. Yue, C. Huang, and Z. Song. 2007. Ultrasensitive assay of gatifloxacin at picogram level based on its enhancing effect on the myoglobin-luminol chemiluminescence reaction. Anal. Lett. 40: 1951-1961.
132. 2- norfloxacin chemiluminescence system and its applications. Luminescence 20: 220-225.
133. Xu, L., Z. Y. Huang, and Z. H. Chen. 1995. Determination of norfloxacin by beta cyclodextrin. Fenxi-Kexue-Xuebao 11: 72.
134. Xu, L. Y., and W. Q. Yu. 2004. The fluorescence characteristics of norfloxacin and its application. Guang Pu Xue Yu Guang Pu Fen Xi 24: 1615-1617.
135. Xu, Q. Q., L. M. Du, and J. P. Wang. 2002. Study on the direct determination of lomefloxacin in urine by derivative-synchronous fluorescence. Guang Pu Xue Yu Guang Pu Fen Xi 22: 444-445.
136. Xu, Y., H. X. Shen, and H. G. Huang. 1997. The fluoresence characteristics of norfloxacin- Mguanylic acid reaction product and its determination. Fenxi-Huaxue 25: 419.
137. Yan, L., Z. Chun, C. Y. Sun, and Y. Lin. 2002. Terbium sensitized chemiluminescence determination of rufloxacin hydrochloride. Pharm. J. 37.
138. Yan, L., Z. Chun, C. Sun, Y. Lin, and C. Yue. 2004. A study on the sensitized chemiluminescence of terbium-tosufloxacin. J. Lab. Anal. Vol. 23.
139. Yang, C., Z. Zhang, S. Chen, and F. Yang. 2007. Molecularly imprinted on-line solid-phase extraction combined with chemiluminescence for the determination of pazufloxacin mesilate. Microchim. Acta 159: 299-304.
140. Yang, Z. J., H. C. Zhao, F. Ding, A. Y. Li, and X. L. Wang. 2007. Nanosilver sensitized fluorescence and second-order scattering of Tb (III)-norfloxacin and its application. Guang Pu Xue Yu Guang Pu Fen Xi 27: 2534-2537.
141. Yi, L., H. Zhao, S. Chen, L. Jin, D. Zheng, and Z. Wu. 2003. Flow-injection analysis of two fluoquinolones by the sensitizing effect of terbium(III) on chemiluminescence of the potassium permanganate-sodium sulfite system. Talanta 61: 403-409.
142. Yu, X., and J. Bao. 2009. Determination of norfloxacin using gold nanoparticles catalyzed cerium(IV)-sodium sulfite chemiluminescence. J. Lumin. 129: 973-978.
143. Zhang, X., J. Ouyang, S. Zhai, G. Huang, and H. Zhao. 2005. Flow-injection with enhanced chemiluminescence detection of ofloxacin in human plasma. Luminescence 20: 362-369.
144. Zhang, Z., X. Li, X. Wang, S. Chen, B. Song, and H. Zhao. 2006. Determination of ciprofloxacin by flow injection analysis based on chemiluminescence system. J. Rare Earths 24: 285-288.
145. Zhao, H. C., F. Ding, X. Wang, H. Ju, A. Li, and L. P. Jin. 2008. A study on silver nanoparticles-sensitized fluorescence and second-order scattering of the complexes of Tb (III) with ciprofloxacin and its applications. Spectrochim. Acta A 70: 332-336.
146. Zhou, Y., Q. Lu, C. Liu, S. She, and L. Wang. 2005. A novel spectrofluorimetric method for the determination of lomefloxacin based on supramolecular inclusion complex between it and p-sulfonated calyx[4] arene. Anal. Chim. Acta 552: 152-159.
147. Zhou, Y., Q. Lu, C. Liu, S. She, and L. Wang. 2006. Spectrofluorimetric study on the inclusion interaction between lomefloxacin and p-sulfonated calix[4]arene and its analytical application. Spectrochim. Acta A 64: 748-756.
148. Zhu, X., A. Gong, and S. Yu. 2008. Fluorescence probe enhanced spectrofluorimetric method for the determination of gatifloxacin in pharmaceutical formulations and biological fluids. Spectrochim. Acta A 69: 478-482.